Digital diagnostics company ixlayer announced it will produce CVS Health's branded at-home sample collection kits. 

Ixlayer's kits can test for Lyme disease, Vitamin D levels, thyroid function and sexually transmitted infections. Users are also provided education and information about what the results mean. 

Consumers can now purchase the CVS Health-branded tests online or pick up a test in-store at select CVS locations. 

Once purchased, the tester activates their account and sends their sample in a prepaid mailer. Through ixlayer, test results are provided to consumers via an online portal. 

"With nearly 70% of medical decisions dependent on lab testing, regular diagnostic testing is a cornerstone of improving health and wellness," Pouria Sanae, CEO and cofounder of ixlayer, said in a statement. "At-home testing enables people to proactively take control of their health, on their own schedule, in the privacy of their own home and on a regular basis."

THE LARGER TREND

The at-home testing market has grown, and investors have taken notice. 

Morgan Health, JP Morgan Chase's healthcare business unit, announced a $20 million strategic investment in LetsGetChecked, a company offering at-home testing for sexual health, diabetes, fertility hormones, cholesterol and COVID-19.

LetsGetChecked closed a $150 million Series D funding round in 2021, building on raises in 2018, 2019 and 2020. 

In April, diagnostics giant Labcorp partnered with Getlabs to offer at-home sample collection for lab tests.

The service, Getlabs for Labcorp, allows users to schedule an appointment online for an at-home blood draw. A phlebotomist can collect samples of saliva, stool, urine and breath, and measure vital signs. The collection costs a convenience fee starting at $25. 

Fla.-based Getlabs, which also delivers specimens for Quest Diagnostics, scored $20 million in Series A financing earlier this year.